title: Biology of brain metastases and novel targeted therapies: time to translate the research.
abstract: Brain metastases (BM) occur in 20% to 40% of patients with cancer and result in significant morbidity and poor survival. The main therapeutic options include surgery, whole brain radiotherapy, stereotactic radiosurgery and chemotherapy. Although significant progress has been made in diagnostic and therapeutic methods, the prognosis in these patients remains poor. Furthermore, the poor penetrability of chemotherapy agents through the blood brain barrier (BBB) continues to pose a challenge in the management of this disease. Preclinical evidence suggests that new targeted treatments can improve local tumor control but our clinical experience with these agents remains limited. In addition, several clinical studies with these novel agents have produced disappointing results. This review will examine the knowledge of targeted therapies in BM. The preclinical and clinical evidence of their use in BM induced by breast cancer, non-small cell lung cancer and melanoma will be presented. In addition, we will discuss the role of antiangiogenic and radiosensitising agents in the treatment of BM and the current strategies available to increase BBB permeability. A better understanding of the mechanism of action of these agents will help us to identify the best targets for testing in future clinical studies.
authors.affiliation: Department of Radiation Therapy and Oncology, Johann Wolfgang Goethe University, Frankfurt, Germany. emmanouil.fokas@kgu.de
authors.forename: Emmanouil
authors.initials: E
authors.lastname: Fokas
authors.forename: Joachim P
authors.initials: JP
authors.lastname: Steinbach
authors.forename: Claus
authors.initials: C
authors.lastname: Rödel
mesh_terms: D000818:Animals; D001812:Blood-Brain Barrier / Q000473:pathology; D001932:Brain Neoplasms / Q000098:blood supply / Q000556:secondary* / Q000628:therapy*; D006801:Humans; D009389:Neovascularization, Pathologic / Q000473:pathology / Q000628:therapy; D057170:Translational Research, Biomedical